Our April 28, 2022 featured Klazina Kooiman, Ph.D. from Erasmus MC University Medical Center Rotterdam presenting:

"Sonobactericide for Treating Bacterial Infections"

About the Professor

Klazina Kooiman received the M.Sc. degree with honors (cum laude) in biopharmaceutical sciences specializing in pharmaceutical technology from Leiden University, Leiden, the Netherlands, in 2000, and the Ph.D. degree in ultrasound contrast agents for therapy from the Department of Biomedical Engineering, Thoraxcenter, Erasmus MC University Medical Center Rotterdam, the Netherlands, in 2011. She is currently an Associate Professor and the Head of the Therapeutic Ultrasound Contrast Agent Group, Department of Biomedical Engineering, Thoraxcenter, Erasmus MC University Medical Center Rotterdam. She is the co-director of the Annual European Symposium on Ultrasound Contrast Imaging, Rotterdam, which is attended by approximately 180 scientists from universities and industries all over the world. Her research focuses on the theragnostic field of ultrasound-activated microbubbles (1-8 µm in size) for local drug delivery and ultrasound molecular imaging of cardiovascular disease and cancer. To elucidate the mechanisms of microbubble-mediated drug delivery, she uses multidisciplinary translation technology at the cutting edge of engineering, biology, and pharmacy. The cell types she focuses on are 1) endothelial cells (i.e. the cells that line blood vessels) for vascular drug delivery, and 2) bacterial biofilms for infective endocarditis (i.e. microbial infection of the heart valves and surrounding tissue, including cardiac devices such as pacemakers).

This session was moderated by Mike A. Averkiou, Ph.D., Associate Professor at the Department of Bioengineering, University of Washington.

Mike A. Averkiou is associate professor at the Department of Bioengineering of the University of Washington since 2015. He received a BS, an MS and a PhD in 1987, 1989 and 1994, respectively, all in Mechanical Engineering with specialization in Nonlinear Acoustics/Biomedical Ultrasound, from the University of Texas at Austin. He was a Postdoctoral Fellow at the Applied Physics Laboratory of the University of Washington from 1994 to 1996 and worked on lithotripsy, bubble dynamics, and therapeutic ultrasound. He joined Philips Medical Systems (1996-2005), and worked on diagnostic ultrasound imaging and specifically tissue harmonic imaging, and ultrasound contrast agents. He was associate professor at the Department of Mechanical and Manufacturing Engineering of the University of Cyprus (2005-2015). Mike develops ultrasound imaging and therapy technology for disease detection, improved cancer treatment and monitoring, improved drug delivery to targeted cells, and heart disease. He focuses on transferring innovations from preclinical research into clinical use. He is a senior member of IEEE, Acoustical Society of America fellow and was awarded the Marie Curie Chair of Excellence from the European Commission.

We want to extend our gratitude to our Industry Partner for this webinar. Please visit their online exhibit booth to learn more about their products.